THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

FIRST TRUST ADVISORS LP's Holding History (CIK: 0001125816)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 15,860 Value ($000) $297 Avg Close $16.59 Range $13.50 - $20.33
Q1 2021
Shares 30,564 Value ($000) $624 Avg Close $19.01 Range $16.46 - $21.21
Q3 2020
Shares 43,608 Value ($000) $645 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 77,585 Value ($000) $1,629 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 89,416 Value ($000) $2,066 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 50,692 Value ($000) $1,312 Avg Close $19.43 Range $15.72 - $26.47
Q1 2019
Shares 83,039 Value ($000) $1,882 Avg Close $25.36 Range $21.04 - $28.63
Q4 2018
Shares 87,633 Value ($000) $2,243 Avg Close $27.00 Range $21.70 - $35.48
Q3 2017
Shares 21,118 Value ($000) $723 Avg Close $32.70 Range $23.15 - $42.61
Q2 2017
Shares 12,418 Value ($000) $495 Avg Close $38.45 Range $34.85 - $43.44
Q1 2017
Shares 15,298 Value ($000) $563 Avg Close $31.95 Range $27.80 - $37.18
Q4 2016
Shares 39,755 Value ($000) $1,267 Avg Close $31.02 Range $24.54 - $38.92